PURCHASE ORDER
Active75F40126P00334
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$253.9K
obligated · signed 7 days ago
EO 14398 HUMAN HINDBRAIN ORGANOIDS
Performance timeline
Start
Sep 30, 2026
End
Mar 29, 2028
with all options
Loading status
Estimated start: Mar 29, 2027
ORGANOTHERAPEUTICS GMBH
Contract 75F40126P00334
UEI
KY6GHXV1CLK3
Parent Company
ORGANOTHERAPEUTICS GMBH
Capabilities & Certifications
Headquarters Location
Current Obligation
$253,868
Base + Exercised Options
$253,868
Total Ceiling Value
$253,868
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.